| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Blogging > Powerful Nonprofit Blogging via The Corporate Blogging Book |
|
E-Folder - Powerful Nonprofit Blogging via The Corporate Blogging Book
Whenever I'm diving into something new, I like to have some guidance on hand. Whether I cobble that together from several online sources (of course, I have to know whic According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product h ones are reliable), a peer or workshop, or a handbook, I just need that guidance. Guidance seems to be a basic human need for most folks. So if your nonprofit is ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in blogging, or going to blog, (and you should be), I urge you to plunge into Debbie Weil's just-published guide to organizational blogging, The Corporate Blogging Boo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. . Debbie is my guru on many things online, and a truly original thinker in terms of blogging. Here's what I like about The Corporate Blogging Book:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe all core topics relevant to launching, and maintaining, an organizational blog. So this guide, along with Getting Attention's nonprofit-specific blogging tips d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is all you need to get blogging. I ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc on't know how she does it but Debbie writes and organizes content so that it's universally accessible. She starts by answering the top 20 questions abou easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t corporate blogging, and digs in from there. The reader can go as deep, or stay as shallow, as she likes. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically g that keeps too many nonprofits away. Fear of blogging (takes too much time is the greatest fear) is the barrier to entry I hear from nonprofits time and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nd time again. Debbie confronts fear straight on, acknowledging its frequency and providing clear, practical guidelines on how to avert whatever your no ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi profit fears most. Her anti-fear strategies include interviewing peer nonprofits that are blogging before you start, and drafting comprehensive organizational ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a blogging guidelines. ROI, ROI, ROI. That's all I've heard for dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the last few years as the framework for blog impact. Now Debbie suggests that ROB (return on blog) is what you're looking for, and demonstrates what cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that'll do for your nonprofit. By the way, the ROB your nonprofit should focus on is continued conversations with your target audiences. Remember, its conv tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ersing with the right audiences, not the sheer volume of traffic, that matters. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel mbling point once nonprofits decide to blog. Debbie's coverage includes:
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ls and technology that are right for your nonprofit. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products gging models – at both Fortune 500 and small-business level, that serve as real-life inspiration (and proof) of how blogging will benefit your nonprofit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de The Corporate Blogging Book, paired with the nonprofit-specific blogging guidance I provide in the Getting Attention blog and e-newsletter (links below elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip , will take your nonprofit to blogging success. Move forward. Order Weil's guidebook today: http://tinyurl.com/hofml tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:5 Tips for Developing Good Blog Topics
|